Kerstin Papenfuss

Deep Science Ventures Ltd. (Deep Science Ventures) is a venture capital firm founded 2016 by Mark Hammond and Dominic Falcão. The firm is headquartered in Essex, United Kingdom.

Antiverse Ltd. is building a world-first computational antibody drug discovery platform. It specializes in machine learning, antibodies, and drug discovery. The company was founded by Murat Tunaboylu, Rowina Westermeier and Ben Holla Holland and is headquartered in Cardiff, the United Kindom.

Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom.